Hyaluronate lyase (4.2.2.1)

Industry

CPC
C12Y402/02001

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y402/00Carbon-oxygen lyases (4.2)

Current Industry

C12Y402/02001Hyaluronate lyase (4.2.2.1)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 11,246,915
- Issue date Feb 15, 2022
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of retinal degeneration using gene therapy
- Patent number 10,912,845
- Issue date Feb 9, 2021
- The University of Manchester
- Robert Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 10,799,565
- Issue date Oct 13, 2020
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 10,786,555
- Issue date Sep 29, 2020
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 10,786,556
- Issue date Sep 29, 2020
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 10,624,955
- Issue date Apr 21, 2020
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 10,624,957
- Issue date Apr 21, 2020
- Applies Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cholix toxin-derived fusion molecules for oral delivery of biologic...
- Patent number 10,624,956
- Issue date Apr 21, 2020
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating and preventing social communication disorder in...
- Patent number 10,279,012
- Issue date May 7, 2019
- HealthPartners Research & Education
- William H. Frey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thermally stable enzymes, compositions thereof and methods of using...
- Patent number 9,546,361
- Issue date Jan 17, 2017
- Lehigh University
- Bryan William Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteoglycan degrading mutants for treatment of CNS
- Patent number 9,528,102
- Issue date Dec 27, 2016
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins for the treatment of CNS
- Patent number 8,906,363
- Issue date Dec 9, 2014
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteoglycan degrading mutants for the treatment of CNS
- Patent number 7,968,089
- Issue date Jun 28, 2011
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteoglycan degrading mutants for the treatment of CNS
- Patent number 7,429,375
- Issue date Sep 30, 2008
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Hyaluronate lyase used for promoting penetration in topical agents
- Patent number 6,719,986
- Issue date Apr 13, 2004
- esparma GmbH
- Wolfgang Wohlrab
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20240226243
- Publication date Jul 11, 2024
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20240207372
- Publication date Jun 27, 2024
- Thornhill Therapeutics, Inc.
- Randall J. Mrsny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20240131118
- Publication date Apr 25, 2024
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
A MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PRODUCTION PROCESS,...
- Publication number 20230167428
- Publication date Jun 1, 2023
- PHARMACT HOLDING AG
- Gunther BURGARD
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20220226445
- Publication date Jul 21, 2022
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods Employing Mucin-Specific Proteases
- Publication number 20220003777
- Publication date Jan 6, 2022
- The Board of Trustees of the Leland Stanford Junior University
- Carolyn R. Bertozzi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY
- Publication number 20210330812
- Publication date Oct 28, 2021
- The University of Manchester
- Robert Lucas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20210220446
- Publication date Jul 22, 2021
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20210205420
- Publication date Jul 8, 2021
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20200030417
- Publication date Jan 30, 2020
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIPOPROTEIN EXPORT SIGNALS AND USES THEREOF
- Publication number 20190194264
- Publication date Jun 27, 2019
- Universite de Namur
- Frédéric André Lauber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20190117743
- Publication date Apr 25, 2019
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20190117744
- Publication date Apr 25, 2019
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20190117742
- Publication date Apr 25, 2019
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...
- Publication number 20190105375
- Publication date Apr 11, 2019
- Applied Molecular Transport Inc.
- Randall J. Mrsny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY
- Publication number 20160361437
- Publication date Dec 15, 2016
- The University of Manchester
- Robert Lucas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Enzyme Hyaluronan-Lyase, Method of Production Thereof, Use Thereof...
- Publication number 20150344926
- Publication date Dec 3, 2015
- Contipro Biotech s.r.o.,
- Lenka Knorova
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Thermally Stable Enzymes, Compositions Thereof and Methods of Using...
- Publication number 20150284703
- Publication date Oct 8, 2015
- LEHIGH UNIVERSITY
- Bryan William Berger
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
- Publication number 20140322192
- Publication date Oct 30, 2014
- ACORDA THERAPEUTICS, INC.
- Elliott A. GRUSKIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING AND PREVENTING SOCIAL COMMUNICATION DISORDER IN...
- Publication number 20140255384
- Publication date Sep 11, 2014
- HealthPartners Research & Education
- William H. Frey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
- Publication number 20110250631
- Publication date Oct 13, 2011
- Elliott A. GRUSKIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Proteoglycan Degrading Mutants for the Treatment of CNS
- Publication number 20090041728
- Publication date Feb 12, 2009
- ACORDA THERAPEUTICS, INC.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fusion proteins for the treatment of CNS
- Publication number 20090028829
- Publication date Jan 29, 2009
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Proteoglycan degrading mutants for the treatment of CNS
- Publication number 20060233782
- Publication date Oct 19, 2006
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mammalian mucinase, its recombinant production, and its use in ther...
- Publication number 20040253224
- Publication date Dec 16, 2004
- Johannes Maria Franciscus Gerardus Aerts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mammalian mucinase, its recombinant production, and its use in ther...
- Publication number 20030087414
- Publication date May 8, 2003
- Johannes Maria Franciscus Gerardus Aerts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hyaluronate lyase (4.2.2.1)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Treatment of retinal degeneration using gene therapy

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Cholix toxin-derived fusion molecules for oral delivery of biologic...

Methods of treating and preventing social communication disorder in...

Thermally stable enzymes, compositions thereof and methods of using...

Proteoglycan degrading mutants for treatment of CNS

Fusion proteins for the treatment of CNS

Proteoglycan degrading mutants for the treatment of CNS

Proteoglycan degrading mutants for the treatment of CNS

Hyaluronate lyase used for promoting penetration in topical agents

Patents Applicationslast 30 patents

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

A MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PRODUCTION PROCESS,...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

Methods Employing Mucin-Specific Proteases

TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

LIPOPROTEIN EXPORT SIGNALS AND USES THEREOF

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGIC...

TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY

Enzyme Hyaluronan-Lyase, Method of Production Thereof, Use Thereof...

Thermally Stable Enzymes, Compositions Thereof and Methods of Using...

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

METHODS OF TREATING AND PREVENTING SOCIAL COMMUNICATION DISORDER IN...

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

Proteoglycan Degrading Mutants for the Treatment of CNS

Fusion proteins for the treatment of CNS

Proteoglycan degrading mutants for the treatment of CNS

Mammalian mucinase, its recombinant production, and its use in ther...

Mammalian mucinase, its recombinant production, and its use in ther...